The global Omega-3 Concentrates market is estimated to be worth USD 2.9 billion in 2024 and is projected to reach a value of USD 5.7 Billion by 2034, expanding at a CAGR of 7.0% over the assessment period of 2024 to 2034
Sales of Omega- 3 Concentrates have exhibited a spike over the past few years, driven by the increasing consumer interest in functional foods and beverages, that offers additional health benefits beyond basic nutrition, which is boosting the composition of omega-3 concentrates in these products.
This is stimulated by the rising awareness of omega-3's function in promoting heart health, improving cognitive function, and reducing inflammation. Consequently, manufacturers are including omega-3 concentrates into a diversity of food and beverage products to meet the demand for healthy alternatives.
This not only refines the nutritional composition of these products but also fits in with the consumers' desire for convenient, health-enhancing dietary preferences.
The rising shift towards nutraceutical products derived from food sources that offer health benefits and aid in disease prevention and treatment is drastically driving market demand.
Consumers are increasingly seeking natural, health-enhancing alternatives, leading to a surge in the popularity of nutraceuticals. Omega-3 concentrates are known for their cardiovascular, cognitive, and anti-inflammatory benefits, and are mostly in demand. This shift towards wellness-focused consumption is boosting the integration of omega-3 concentrates into a diversity of nutraceutical products.
| Attributes | Description |
|---|---|
| Estimated Global Omega- 3 Concentrates Industry Size (2024E) | USD 2.9 Billion |
| Projected Global Omega- 3 Concentrates Industry Value (2034F) | USD 5.7 Billion |
| Value-based CAGR (2024 to 2034) | 7.0% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The below table presents a comparative assessment of the variation in CAGR over six months for the base year (2023) and current year (2024) for global omega-3 concentrate market.
This analysis reveals crucial shifts in market performance and indicates revenue realization patterns, thus providing stakeholders with a better vision about the market growth trajectory over the year. The first half of the year, or H1, spans from January to June. The second half, H2, includes the months from July to December.
| Particular | Value CAGR |
|---|---|
| H1 | 5.4% (2023 to 2033) |
| H2 | 5.7% (2023 to 2033) |
| H1 | 6.3% (2024 to 2034) |
| H2 | 6.8% (2024 to 2034) |
The above table presents the expected CAGR for the global omega-3 concentrate demand space over semi-annual period spanning from 2024 to 2034. In the first half (H1) of the year 2023, the business is predicted to surge at a CAGR of 5.4%, followed by a slightly higher growth rate of 5.7% in the second half (H2) of the same year.
Moving into year 2024, the CAGR is projected to increase slightly to 6.3% in the first half and remain relatively moderate at 6.8% in the second half. In the first half (H1 2024) the market witnessed a decrease of 19 BPS while in the second half (H2 2024), the market witnessed an increase of 32 BPS.
Omega-3 Fortification in Infant Formula is Gaining Momentum
Growing awareness of DHA's vital role in infant brain and visual development is considerably driving the inclusion of omega-3 concentrates in infant formula. DHA, a key omega-3 fatty acid, is essential for proper neurological and visual functioning in infants. Parents and healthcare specialist are progressively recognizing its importance, which is leading to a higher demand for fortified infant formulas.
Due to which, manufacturers are producing products with enhanced omega-3 concentrates to meet this growing demand, and ensuring infants receive optimal nutrition for healthy development during the crucial early stages of life.
Expanding Use of Omega-3 Concentrates in Personal Care and Cosmetics
The use of omega-3 concentrates in personal care and cosmetic products is expanding due to their proven skin health and anti-inflammatory properties. Omega-3 fatty acids help maintain skin hydration, improve elasticity, and reduce signs of aging by tackling inflammation and promoting cell membrane health.
As consumers become more health-conscious and are seeking natural ingredients, the demand for skincare and cosmetic products enriched with omega-3s is growing. This encourages manufacturers to innovate and include these beneficial concentrates in a wider range of beauty and personal care products.
Rise of Algae-Based Omega-3s: Meeting Sustainability Demands
There is a distinct shift towards sustainably sourced omega-3 fatty acids, particularly from algae-based products, driven by increasing environmental awareness among consumers. Algae-based omega-3 sources are considered as more eco-friendly compared to traditional fish-derived sources, which helps reduce concerns over marine ecosystem depletion.
This drift reflects a broader consumer preference for products that minimize environmental impact and promote sustainable practices. As awareness grows about the benefits of algae-based omega-3s, such as reduced environmental footprint and potential purity advantages, more consumers are opting for these sustainable alternatives for their dietary supplements and functional foods.
Principal Consultant
Global Omega-3 Concentrates sales increased at a CAGR of 5.9% from 2019 to 2023. For the next ten years (2024 to 2034), projections are that expenditure on Omega- 3 Concentrates will rise at 7.0% CAGR
The rising popularity of dietary supplements as a means to enhance overall health and wellness has been a major stimulant for the growth of the omega-3 concentrate market.
Consumers are increasingly switching to supplements to complement their diets and address specific health concerns, including cardiovascular health, cognitive function, and inflammation reduction, domains where omega-3 fatty acids are well known to provide major benefits.
This shift is driven by growing health consciousness and the desire for preventive healthcare measures, pushing manufacturers to innovate and expand their offerings of omega-3 concentrates in various forms to meet the increasing demand in the supplement market.
Increasing awareness of pet health and nutrition is prompting the inlusion of omega-3 concentrates into pet food formulations. Omega-3 fatty acids, such as DHA and EPA, offer benefits for pets similar to those for humans, including support for joint health, coat condition, and overall immune system function.
As pet owners are searching to provide optimal nutrition for their animals, omega-3 enrichment in pet foods is becoming a essential attribute in meeting these health-conscious demands.
Tier 1 companies comprise industry leaders with market revenue of above USD 50 million capturing significant sales domain share of 45% to 55% in the global sphere. These business leaders are characterized by high production capacity and a wide product portfolio.
These trade leaders are distinguished by their extensive expertise in manufacturing and reconditioning across multiple packaging formats and a broad geographical reach, underpinned by a robust consumer base. Prominent companies within tier 1 include BASF SE, Nordic Naturals, DSM, ADM, and Corbion
Tier 2 companies include mid-size players with revenue of USD 10 to 50 million having presence in specific regions and highly influencing the local retail space. These are characterized by a strong presence overseas and strong consumer base knowledge.
These industry players have good technology and ensure regulatory compliance but may not have advanced technology and wide global reach. Prominent companies in tier 2 include Epax, GC Rieber (VivoMega), AlaskOmega, Norwegian Fish Oil, Golden Omega, KD Pharma Group, Orkla Health, and Olvea Omega Solutions
Tier 3 includes the majority of small-scale companies operating at the local presence and serving niche demand space having revenue below USD 10 million. These companies are notably oriented towards fulfilling local marketplace demands and are consequently classified within the tier 3 share segment.
They are small-scale players and have limited geographical reach. Tier 3, within this context, is recognized as an unorganized field, denoting a sector characterized by a lack of extensive structure and formalization when compared to organized competitors.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below highlights revenue from product sales in key countries. The China and Japan are predicted to remain top consumers, with estimated trade valuations of USD 699.6 million and USD 598.9 million, respectively, by 2034.
| Countries | Market Value (2034) |
|---|---|
| China | USD 699.6 million |
| Japan | USD 598.9 million |
| India | USD 519.4 million |
| USA | USD 164.3 million |
| Australia | USD 127.2 million |
The following table shows the estimated growth rates of the top five sales domain. India and China are set to exhibit high Omega- 3 Concentrates consumption, recording CAGRs of 5.9% and 5.5%, respectively, through 2034.
| Countries | CAGR 2024 to 2034 |
|---|---|
| China | 5.5% |
| Japan | 5.3% |
| India | 5.9% |
| USA | 4.9% |
| Australia | 4.6% |
The demand space for Omega- 3 Concentrates in the Japan is projected to exhibit a CAGR of 5.3% during the assessment period. By 2034, revenue from the sales of Omega- 3 Concentrates in the country is expected to reach USD 598.9 Million.
Japan's aging population is one of the world's most prominent, has increased the requirement for health supplements aimed at reducing age-related issues. Omega-3 fatty acids, popular for their anti-inflammatory properties and contributions to heart and brain health, are especially appealing to older adults pursuing to maintain cognitive sharpness and cardiovascular well-being.
This demographics’ amplified health consciousness and proactive approach to aging, linked with widespread scientific endorsement of omega-3 benefits, drive strong market interest in Japan. As a result, products enriched with omega-3 concentrates are consequently featured in the country's healthcare and wellness strategies aimed at supporting longevity and quality of life.
Omega- 3 Concentrates demand in India is calculated to rise at a value CAGR of 5.9% during the forecast period (2024 to 2034). By 2034, India is expected to account for 32.6% of Omega- 3 Concentrates sales in East Asia.
Most of the Indians experience dietary deficiencies in essential nutrients like omega-3 fatty acids, determined by traditional diets that often lack adequate fish consumption. This deficiency has boosted interest in omega-3 supplements as a convenient solution to bridge nutritional gaps and support overall health.
Simultaneously, the rising frequency of lifestyle-related diseases such as cardiovascular conditions, diabetes, and cognitive decline has pointed out the importance of preventive healthcare strategies.
Omega-3 supplements are incrementally getting recognized as a proactive measure to reduce these health risks, promoting their adoption among individuals looking to maintain or improve their long-term health issues in India's evolving healthcare environment.
Consumption of Omega- 3 Concentrates in USA is projected to increase at a value CAGR of 4.9% over the next ten years. By 2034, the business size is forecasted to reach USD 164.3 Million, with China expected to account for a domain share of 78.3% in East Asia.
Omega-3s has gained popularity among athletes and fitness enthusiasts in the USA because of their perceived benefits for joint health, reducing inflammation, and enhancing overall physical performance. These fatty acids are considered to support recovery and reduce exercise-induced muscle soreness, which makes them a preferred supplement in the fitness community.
While, ongoing product innovation has further boosted their appeal. Advances such as higher concentrations and improved food attributes in omega-3 supplements cater to consumer preferences for effectiveness and palatability, further driving greater acceptance and integration of these products into daily health routines among active individuals in the country.
| Segment | Fish (Source) |
|---|---|
| Value Share (2024) | 41.6% |
Sales of fish sourced Omega- 3 Concentrates are projected to register a CAGR of 5.7% from 2024 to 2034. Fish-sourced omega-3s, especially in the form of triglycerides, are often more bioavailable and easily absorbed by the body compared to plant-based or other sources, which ensures more efficient utilization of these essential fatty acids.
Extensive research and clinical studies have shown the health benefits of fish-derived omega-3 fatty acids, specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid).
These benefits include improved heart health, cognitive function, and anti-inflammatory properties, making them highly sought after. Furthermore, fish oil concentrates typically contain higher levels of EPA and DHA compared to plant-based omega-3 sources. This higher concentration means that consumers can achieve therapeutic benefits with smaller doses, enhancing the appeal and effectiveness of fish-sourced omega-3 supplements.
| Segment | Food & Beverages (End Use) |
|---|---|
| Value Share (2024) | 38.2% |
The Food & Beverages segment is anticipated to advance at 6.2% CAGR during the projection period.
Food and beverage companies are determined to differentiate their products in a competitive marketplace by adding omega-3 concentrates. This addition allows them to trade their offerings as health-enhancing, appealing to the growing segment of health-conscious consumers pursuing functional benefits from their food and beverages.
Moreover, many consumers suffer from nutritional deficiencies, particularly in omega-3 fatty acids, due to insufficient dietary intake of fish and other sources. Fortifying foods and beverages with omega-3s provides a convenient solution for increasing omega-3 intake without requiring crucial change in eating habits.
This fortification benefits consumers to meet their nutritional needs easily, supporting overall health and wellness, and further driving the demand for omega-3-enriched products in the market.
The Omega- 3 Concentrates market encompasses a diverse and dynamic competitive landscape. Leading Omega- 3 Concentrates manufacturing companies are focusing on research and development, sustainable sourcing, and new formulations. They are also emphasizing environment-friendly practices and product certifications to satisfy the increasing demand for natural and sustainable ingredients.
For instance
As per form, the market has been categorized into powder and oil
This segment is further categorized into krill, fish, calamari, algae, and others
As per type, the market has been categorized into triglyceride (TG), ethyl ester (EE), and phospholipids (PL)
This segment is further categorized into High DHA, High EPA, and Balanced EPA: DHA
As per end use, the market has been categorized into food and beverages, dietary supplements, pharmaceuticals, nutraceuticals, infant formula, personal care and cosmetics, and pet food
This segment is further categorized into drums and totes
Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.
The global Omega- 3 Concentrates market is estimated at a value of USD 2.9 billion in 2024.
Sales of Omega- 3 Concentrates increased at 5.9% CAGR between 2019 and 2023.
BASF SE, Nordic Naturals, DSM, ADM, Corbion, Epax, GC Rieber (VivoMega), and AlaskOmega are some of the leading players in this market.
The East Asian market is projected to hold a revenue share of 32.4% over the forecast period.
North America holds a 9.4% share of the global market for Omega- 3 Concentrates.
1. Executive Summary
2. Industry Introduction, Including Taxonomy and Market Definition
3. Market Trends and Success Factors, Including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Pricing Analysis
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
6.1. Form
6.2. Source
6.3. Type
6.4. Concentration
6.5. End Use
6.6. Packaging
6.7. Region
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Form
7.1. Powder
7.2. Oil
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Source
8.1. Krill
8.2. Fish
8.3. Calamari
8.4. Algae
8.5. Others
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Type
9.1. Triglyceride (TG)
9.2. Ethyl Ester (EE)
9.3. Phospholipids (PL)
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Concentration
10.1. High DHA
10.2. High EPA
10.3. Balanced EPA: DHA
11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End Use
11.1. Food and Beverages
11.2. Dietary Supplements
11.3. Pharmaceuticals
11.4. Nutraceuticals
11.5. Infant Formula
11.6. Personal Care and Cosmetics
11.7. Pet Food
12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Packaging
12.1. Drums
12.2. Totes
13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
13.1. North America
13.2. Latin America
13.3. Europe
13.4. East Asia
13.5. South Asia
13.6. Oceania
13.7. Middle East and Africa
14. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
17. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
18. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
19. Oceania Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
20. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
21. Sales Forecast 2024 to 2034 by Category A, Category B, and Category C for 30 Countries
22. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
23. Company Profile
23.1. Australian Omega Oils Pty. Ltd.
23.2. BASF SE
23.3. Epax
23.4. GC Rieber (VivoMega)
23.5. AlaskOmega
23.6. Norwegian Fish Oil
23.7. Nordic Naturals
23.8. DSM
23.9. Golden Omega
23.10. ADM
23.11. KD Pharma Group
23.12. Corbion
23.13. Orkla Health
23.14. Olvea Omega Solutions
Explore Food and Beverage Insights
View Reports
Omega-3 Concentrates Market
